JMY expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.146800E-01
Normal-vs-Stage2
2.726800E-01
Normal-vs-Stage3
1.783910E-02
Normal-vs-Stage4
4.731600E-01
Stage1-vs-Stage2
4.488300E-02
Stage1-vs-Stage3
4.658100E-02
Stage1-vs-Stage4
4.437000E-01
Stage2-vs-Stage3
1.534410E-01
Stage2-vs-Stage4
6.387400E-01
Stage3-vs-Stage4
3.875800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.856200E-01
Normal-vs-AfricanAmerican
7.362600E-01
Normal-vs-Asian
2.131000E-01
Caucasian-vs-AfricanAmerican
5.180800E-01
Caucasian-vs-Asian
3.110800E-01
AfricanAmerican-vs-Asian
2.764600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.551600E-01
Normal-vs-Female
4.295800E-01
Male-vs-Female
6.963400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.859800E-01
Normal-vs-Age(41-60Yrs)
7.140800E-01
Normal-vs-Age(61-80Yrs)
2.554800E-01
Normal-vs-Age(81-100Yrs)
1.548180E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.730000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.785450E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.468980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.160000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.075900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.520000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.037600E-02
Normal-vs-Daily Drinker
1.947630E-01
Normal-vs-Weekly Drinker
2.058400E-01
Normal-vs-Occasional Drinker
4.666600E-01
Normal-vs-Social Drinker
9.820400E-01
Non Drinker-vs-Daily Drinker
3.227800E-01
Non Drinker-vs-Weekly Drinker
6.871200E-01
Non Drinker-vs-Occasional Drinker
1.986320E-02
Non Drinker-vs-Social Drinker
5.188400E-02
Daily Drinker-vs-Weekly Drinker
7.219400E-01
Daily Drinker-vs-Occasional Drinker
2.330600E-01
Daily Drinker-vs-Social Drinker
1.385950E-01
Weekly Drinker-vs-Occasional Drinker
1.834410E-01
Weekly Drinker-vs-Social Drinker
1.161390E-01
Occasional Drinker-vs-Social Drinker
4.104600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.445410E-01
Normal-vs-Grade 2
4.711800E-02
Normal-vs-Grade 3
2.395900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.032000E-01
Grade 1-vs-Grade 3
2.532200E-01
Grade 1-vs-Grade 4
1.445410E-01
Grade 2-vs-Grade 3
7.988200E-01
Grade 2-vs-Grade 4
4.711800E-02
Grade 3-vs-Grade 4
2.395900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.334800E-01
Normal-vs-NonDiabetic
3.352400E-01
Diabetic-vs-NonDiabetic
9.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.191600E-01
Normal-vs-NoPancreatitis
3.055000E-01
Pancreatitis-vs-NoPancreatitis
9.636400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.563200E-01
Normal-vs-N1
2.427200E-01
N0-vs-N1
5.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.627640E-01
Normal-vs-TP53-NonMutant
7.930000E-01
TP53-Mutant-vs-TP53-NonMutant
4.415900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
